<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xml:lang="hr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-143-470</article-id>
<article-id pub-id-type="doi">10.26800/LV-143-11-12-8</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Drugs and procedures</subject></subj-group>
</article-categories>
<title-group>
<article-title>Audiovestibularni simptomi infekcije COVID-19</article-title>
<trans-title-group xml:lang="en">
<trans-title>Audiovestibular symptoms of COVID-19 infection</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Klan&#x010D;nik</surname><given-names>Marisa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ivani&#x0161;evi&#x0107;</surname><given-names>Petar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Poljak</surname><given-names>Nikola Kolja</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Drvi&#x0161;</surname><given-names>Petar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution content-type="dept">Klinika za bolesti uha, nosa i grla s kirurgijom glave i vrata</institution>, <institution>KBC Split</institution></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Adresa za dopisivanje: Petar Ivani&#x0161;evi&#x0107;, dr. med., Klinika za bolesti uha, nosa i grla s kirurgijom glave i vrata, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Splitu, KBC Split, Spin&#x010D;i&#x0107;eva 1, 21000 Split, e-po&#x0161;ta: <email xlink:href="pivanisevic@kbsplit.hr">pivanisevic@kbsplit.hr</email>&#x2028;<italic>Primljeno 3. o&#x017E;ujka 2021., prihva&#x0107;eno 8. rujna 2021.</italic></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>12</month><year>2021</year></pub-date>
<volume>143</volume>
<issue>11-12</issue>
<fpage>470</fpage>
<lpage>472</lpage>
<permissions>
<copyright-year>2021</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<p>Iako naj&#x010D;e&#x0161;&#x0107;e zahva&#x0107;a gornji respratorni sustav sa simptomima vru&#x0107;ice, ka&#x0161;lja i umora, novi virus SARS-CoV-2 mo&#x017E;e dovesti do pneumonije i te&#x017E;ih komplikacija poput multiorganskog zatajenja. Kako pandemija napreduje i poga&#x0111;a sve ve&#x0107;i broj osoba, pojavljuju se sve vi&#x0161;e simptomi koji nisu usko povezani s gornjim di&#x0161;njim sustavom. Javljaju se gastrointestinalni simptomi, neurolo&#x0161;ki i kardiolo&#x0161;ki simptomi, ko&#x017E;ne promjene te simptomi unutra&#x0161;njeg i srednjeg uha poput gubitka sluha, tinitusa, otalgije i vrtoglavica. Mogu&#x0107;a patogeneza virusno-induciranog gubitka sluha jest u direktnom o&#x0161;te&#x0107;enju struktura unutra&#x0161;njeg uha ili u imunolo&#x0161;ki posredovanom odgovoru. Cilj rada je analizirati i prikazati bolesnike s gubitkom sluha, tinitusom i vrtoglavicom kao klini&#x010D;kim manifestacijama infekcije SARS-CoV-2. Analizirirali smo 25 bolesnika u dobi izme&#x0111;u 33 i 70 godina koji se se javili u audiolo&#x0161;ku ambulantu u vremenu od 1. prosinca 2020. godine do 6. velja&#x010D;e 2021. godine sa simptomima gubitka sluha, tinitusom i vrtoglavicom. Rezultati studije pokazuju da je do&#x0161;lo do akutnoga jednostranog gubitka sluha u dvojice bolesnika, a do akutnoga obostranog u jednog bolesnika tijekom infekcije SARS-CoV-2. U jednog bolesnika je do&#x0161;lo do potpunog oporavka sluha nakon kortikosteroidne terapije, a u dvojice do djelomi&#x010D;nog oporavka. Do gubitka sluha samo u visokim frekvencijama na 4000 i 6000 Hz obostrano do&#x0161;lo je u 13 bolesnika. Radi se ujedno o najkarakteristi&#x010D;nijem i naj&#x010D;e&#x0161;&#x0107;em nalazu sluha. Tako&#x0111;er vidimo da je do&#x0161;lo do egzacerbacije tinitusa u 4 bolesnika, a do novonastalnog tinitusa u 11 bolesnika. Vrtoglavica se javila u trojice pacijenata i radi se o novonastalim vrtoglavicama. Iako smo otkrili vezu izme&#x0111;u koronavirusa i gubitka sluha, tinitusa i vrtoglavice, jo&#x0161; uvijek ne znamo prevalenciju audiolo&#x0161;kih manifestacija bolesti jer je i dalje fokus na te&#x017E;im i &#x017E;ivotno ugro&#x017E;avaju&#x0107;im stanjima pa se smetnje sluha i ravnote&#x017E;e &#x010D;esto zanemaruju ili se &#x010D;eka na mogu&#x0107;i spontani oporavak i time gubi dragocjeno vrijeme za lije&#x010D;enje i mogu&#x0107;i br&#x017E;i oporavak.</p>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<p>Although it most commonly affects the upper respiratory system with symptoms of fever, cough, and fatigue, the new SARS-CoV-2 virus can lead to pneumonia and more serious complications such as multiorgan failure. As the pandemic progresses and affects an increasing number of people, more and more symptoms appear that are not closely related to the upper respiratory system. Gastrointestinal symptoms, neurological and cardiac symptoms, and inner and middle ear symptoms such as hearing loss, tinnitus, and dizziness occur. The possible pathogenesis of virus-induced hearing loss is in direct damage to the structures of the inner ear or in an immune-mediated response. The aim of this study was to analyze and present patients with hearing loss, tinnitus and dizziness as clinical manifestations of SARS-CoV-2 infection. We analyzed 25 patients between the ages of 33 and 70 who admitted to the audiology clinic between from December 1, 2020 and to February 6, 2021 with symptoms of hearing loss, tinnitus and dizziness. The results of the study show that there was acute unilateral hearing loss in three patients and acute bilateral hearing loss in one patient during SARS-CoV-2 infection. In one patient there was a complete recovery of hearing after corticosteroid therapy, and in two there was a partial recovery. Hearing loss only at high frequencies at 4000 and 6000 Hz occurred bilaterally in 13 patients. This is both the most characteristic and the most common hearing finding. We also see that exacerbation of tinnitus occurred in four patients and new-onset tinnitus occurred in nine patients. Dizziness occurred in three patients and it was a new-onset dizziness. Although we have discovered a link between coronavirus and hearing loss, tinnitus and dizziness, we still do not know the prevalence of audiological manifestations of the disease because the focus is still on more severe and life-threatening conditions.</p>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori COVID-19 &#x2013; komplikacije</kwd><kwd>GUBITAK SLUHA &#x2013; etiologija</kwd><kwd>VRTOGLAVICA &#x2013; etiologija</kwd><kwd>TINITUS &#x2013; etiologija</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>COVID-19- complications</kwd><kwd>HEARING LOSS &#x2013; etiology</kwd><kwd>VERTIGO &#x2013; etiology</kwd><kwd>TINNITUS &#x2013; etiology</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Iako naj&#x010D;e&#x0161;&#x0107;e zahva&#x0107;a gornji respiratorni sustav sa simptomima vru&#x0107;ice, ka&#x0161;lja i umora, novi virus SARS-CoV-2 mo&#x017E;e dovesti do pneumonije i te&#x017E;ih komplikacija poput multiorganskog zatajenja. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) Stariji bolesnici i bolesnici s komorbiditetom i sistemskim bolestima &#x010D;e&#x0161;&#x0107;e se prezentiraju te&#x017E;om klini&#x010D;kom slikom, respiratornim distres sindromom (ARDS) i &#x201E;citokinskom olujom&#x201C;. Velik broj slu&#x010D;ajeva je asimptomatski ili s blagom klini&#x010D;kom slikom, a kako pandemija napreduje i poga&#x0111;a sve ve&#x0107;i broj osoba, pojavljuju se sve vi&#x0161;e simptomi koji nisu usko povezani s gornjim di&#x0161;njim sustavom. Javljaju se gastrointestinalni simptomi, gubitak njuha i okusa, neurolo&#x0161;ki i kardiolo&#x0161;ki simptomi, ko&#x017E;ne promjene te simptomi unutra&#x0161;njeg i srednjeg uha poput gubitka sluha, tinitusa, otalgije i vrtoglavica. Gubitak sluha i ravnote&#x017E;e predstavlja velik hendikep u socijalnom i psiholo&#x0161;kom smislu te mo&#x017E;e dovesti do izolacije i padova s te&#x017E;im posljedicama.</p>
<p>Od ranije je poznato da virusi mogu uzrokovati blago do te&#x0161;ko o&#x0161;te&#x0107;enje sluha koje mo&#x017E;e biti jednostrano ili obostrano, provodno ili senzoneuralno. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Mogu&#x0107;a patogeneza virusno-induciranog gubitka sluha jest u direktnom o&#x0161;te&#x0107;enju stuktura unutra&#x0161;njeg uha ili u imunolo&#x0161;ki posredovanom odgovoru. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) Virus se mo&#x017E;e indirektno pro&#x0161;iriti na strukture unutra&#x0161;njeg uha iz cerebrospinalnog likvora. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>) Autori Cure i Cure smatraju da je o&#x0161;te&#x0107;enje sluha u oboljelih od infekcije COVID-19 uzrokovano ishemijom slu&#x0161;nog centra zbog trombogenog fenomena povezanog s infekcijom SARS-CoV-2. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>)</p>
<p>Gubitak sluha ili vrtoglavica mo&#x017E;e biti jedini simptom infekcije COVID-19, tako da je va&#x017E;no na vrijeme detektirati o&#x0161;te&#x0107;enje u smislu &#x0161;to ranijeg po&#x010D;etka lije&#x010D;enja i preveniranja trajnog o&#x0161;te&#x0107;enja sluha.</p>
<p>Cilj rada je analizirati i prikazati bolesnike s audiovestibularnim simptomima kao klini&#x010D;kim manifestacijama infekcije SARS-CoV-2.</p>
<sec sec-type="other1">
<title>Materijali i metode</title>
<p>Analizirali smo 25 bolesnika u dobi izme&#x0111;u 33 i 70 godina koji se se javili u audiolo&#x0161;ku ambulantu u vremenu od 1. prosinca 2020. godine do 6. velja&#x010D;e 2021. godine, a nakon izolacije zbog SARS-CoV-2 infekcije, sa simptomima gubitka sluha, tinitusom i vrtoglavicom. Bilo je 17 mu&#x0161;kih bolesnika i 8 &#x017E;enskih bolesnica. Svima su se simptomi javili tijekom aktivne faze bolesti i imali su lak&#x0161;i oblik bolesti. Bolesnici su selektirani prema simptomima gubitka sluha &#x2013; iznenadnog ili postupnog, jednostranog ili obostranog, tinitusa novonastalog ili egzacerbacije postoje&#x0107;eg, te vrtoglavice novonastale ili egzacerbacije postoje&#x0107;e. Tonalna audiometrija je u&#x010D;injena svim bolesnicima, a vestibulometrija onima sa simptomima vrtoglavice.</p>
<p>U utvr&#x0111;ivanju nagluhosti i &#x0161;uma u uhu kori&#x0161;tena je tonalna audiometrija i mjereni su pragovi sluha na 250, 500, 1000, 2000, 3000, 4000, 6000 i 8000 Hz. Uz tonalnu audiometriju u&#x010D;injena je i timpanometrija kako bi se isklju&#x010D;io provodni gubitak sluha. Kohleostapesni refleksi su testirani zbog mogu&#x0107;ega kohlearnog ili retrokohlearnog gubitka sluha. Vizualno analogna skala (VAS) od 1 do 10 (od najbla&#x017E;ih do najte&#x017E;ih simptoma) kori&#x0161;tena je da bismo utvrdili te&#x017E;inu tinitusa. Metoda <italic>Tinnitus handicap inventory</italic> (THI) nije kori&#x0161;tena jer bolesnici u ovom kratkom vremenskom periodu ne mogu donijeti zaklju&#x010D;ke koliko i na koji na&#x010D;in tinitus utje&#x010D;e na sve aspekte &#x017E;ivota, ve&#x0107; samo mogu odrediti te&#x017E;inu tinitusa prethodnom VAS metodom. U dijagnosticiraju vrtoglavica kori&#x0161;teni su klasi&#x010D;ni vestibulometrijski testovi &#x2013; ispitivanje spontanog, poglednog i polo&#x017E;ajnog nistagmusa te toplinski pokus, a u dokazivanju BPPV-a kori&#x0161;ten je Dix-Hallpikeov pokus.</p>
<p>Dostupna literatura ne sugerira nove opcije u terapiji tinitusa, tako da smo bolesnike sa &#x0161;umom u uhu i s nagluho&#x0161;&#x0107;u lije&#x010D;ili glukokortikoidima i betahistinskim preparatima. U bolesnika s vrtoglavicom tako&#x0111;er smo primijenili glukokortikoidnu terapiju u kombinaciji s betahistinima i sedativima.</p>
<p>Svi bolesnici koji su se javili s audiovestibularnim simptomima uklju&#x010D;eni su u istra&#x017E;ivanje.</p>
<p>Istra&#x017E;ivanje je odobrilo Eti&#x010D;ko povjerenstvo KBC-a Split.</p>
</sec>
<sec sec-type="other2">
<title>Rezultati</title>
<p>Rezultati studije pokazuju da je do&#x0161;lo do akutnoga jednostranog gubitka sluha u dvojice bolesnika, a do akutnoga obostranog u jednog bolesnika tijekom infekcije SARS-CoV-2. U jednog bolesnika s jednostranim gubitkom sluha do&#x0161;lo je do potpunog oporavka sluha nakon glukokortikoidne terapije. U ostale dvojice, koji su i dalje u pra&#x0107;enju, do&#x0161;lo je do djelomi&#x010D;nog oporavka. Do gubitka sluha samo u visokim frekvencijama na 4000 i 6000 Hz obostrano do&#x0161;lo je u 13 bolesnika. Radi se ujedno o najkarakteristi&#x010D;nijem i naj&#x010D;e&#x0161;&#x0107;em nalazu sluha. Tako&#x0111;er vidimo da je do&#x0161;lo do egzacerbacije tinitusa u 4 bolesnika, a do novonastalnog tinitusa u 11 bolesnika. Svi bolesnici s pojavom tinitusa imali su obostrani tinitus. Vrtoglavica se javila u trojice bolesnika i radi se o novonastalim vrtoglavicama. U dviju vrtoglavica radilo se o jednostranom vestibularnom neuronitisu, a kod jedne vrtoglavice o BPPV-u (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
<table-wrap id="t1" position="float">
<label>Table 1</label><caption><title>Distribution of patients with tinnitus, hearing loss and vertigo</title>
</caption>
<table frame="hsides" rules="groups">
<col width="20.75%"/>
<col width="25.59%"/>
<col width="31.7%"/>
<col width="21.96%"/>
<thead>
<tr>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Obostrani &#x0161;um<break/>/ Bilateral tinnitus</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Akutni gubitak sluha<break/>/ Sudden hearing loss</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.50pt; border-bottom: solid 0.50pt">Pogor&#x0161;anje postoje&#x0107;eg sluha<break/>/ Exacerbation of hearing loss</th>
<th valign="middle" align="left" scope="col" style="border-left: solid 0.50pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.50pt">Vrtoglavica<break/>/ Vertigo</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left" style="border-left: solid 0.75pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt" scope="row">15</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt">16</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.50pt; border-bottom: solid 0.75pt">4</td>
<td valign="middle" align="left" style="border-left: solid 0.50pt; border-top: solid 0.50pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt">3</td>
</tr>
</tbody></table></table-wrap>
</sec>
<sec sec-type="other3">
<title>Rasprava</title>
<p>Prvi slu&#x010D;aj koji spominje senzorineuralni gubitak sluha u bolesnika pozitivnog na SARS-CoV-2 imao je Sriwijitalaiand Wiwanitkit u travnju 2020. godine. (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>)</p>
<p>Mustafa je izmjerio prijelazne evocirane otoakusti&#x010D;ke emisije (TEOAE) kod 20 bolesnika bez simptoma povezanih s COVID-19 koji su bili pozitivni na SARS-CoV-2 i kod 20 kontrolnih bolesnika te utvrdio da su pozitivni bolesnici sa SARS-CoV-2 imali zna&#x010D;ajno lo&#x0161;ije pragove audiometrije &#x010D;istih tonova na visokim frekvencijama i TEOAE amplitude. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>)</p>
<p>To ukazuje na potencijalni odnos izme&#x0111;u COVID-19 i o&#x0161;te&#x0107;enja pu&#x017E;nice.</p>
<p>SARS-CoV-2 uzrokuje upalni odgovor i pove&#x0107;anje citokina kao &#x0161;to su faktor nekroze tumora, interleukin 1 i interleukin 6. Izravni ulazak u pu&#x017E;nicu i upala koja dovodi do stani&#x010D;nog stresa mehanizmi su koji utje&#x010D;u na trajni senzorineuralni gubitak sluha koji bi se mogao dogoditi u slu&#x010D;aju infekcije SARS-CoV-2. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>)</p>
<p>Tri su mehanizma uklju&#x010D;ena u pojavu SSNHL-a povezanih s virusnim infekcijama: neuritis uzrokovan virusnim zahva&#x0107;anjem pu&#x017E;ni&#x010D;nih &#x017E;ivaca, kohleitis uslijed virusnog zahva&#x0107;anja pu&#x017E;nice i perilimfati&#x010D;nih tkiva te odgovor na stres koji proizlazi iz unakrsne reakcije antigena unutarnjeg uha na virusne infekcije. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>)</p>
<p>Studije na &#x017E;ivotinjama na razli&#x010D;itim virusima izvijestile su o indukcijskom gubitku sluha izravnim zahva&#x0107;anjem struktura unutarnjeg uha ili posredno putem likvora. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>)</p>
<p>Poreme&#x0107;aji sluha i ravnote&#x017E;e mogu ovisiti o vaskularnim o&#x0161;te&#x0107;enjima, jer su strukture unutarnjeg uha posebno osjetljive na ishemiju zbog svojih karakteristika terminalne vaskulature i potrebe za velikom koli&#x010D;inom energije. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>)</p>
</sec>
<sec sec-type="other4">
<title>Zaklju&#x010D;ak</title>
<p>Infekcija SARS-CoV-2 otkriva nam nove klini&#x010D;ke manifestacije koje ujedno mogu biti i jedine manifestacije bolesti. Iako smo otkrili vezu izme&#x0111;u koronavirusa i gubitka sluha, tinitusa i vrtoglavice, jo&#x0161; uvijek ne znamo prevalenciju audiolo&#x0161;kih manifestacija bolesti, jer je i dalje fokus na te&#x017E;im i &#x017E;ivotno ugro&#x017E;avaju&#x0107;im stanjima pa se smetnje sluha i ravnote&#x017E;e &#x010D;esto zanemaruju ili se &#x010D;eka na mogu&#x0107;i spontani oporavak i time gubi dragocjeno vrijeme za lije&#x010D;enje i mogu&#x0107;i br&#x017E;i oporavak. Ujedno je proteklo kratko vrijeme pra&#x0107;enja bolesnika kako bi se dobio definitivni uvid u rezultate lije&#x010D;enja. Potrebna su daljnja istra&#x017E;ivanja s ve&#x0107;im brojem bolesnika i kroz du&#x017E;i period kako bi se dobio bolji i dugoro&#x010D;niji u&#x010D;inak na audiovestibularni sustav i audiovestibularne komplikacije, kao i uvid u mogu&#x0107;i oporavak.</p>
</sec>
</body>
<back>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaim</surname><given-names>S</given-names></name><name><surname>Chong</surname><given-names>JH</given-names></name><name><surname>Sankaranarayanan</surname><given-names>V</given-names></name><name><surname>Harky</surname><given-names>A</given-names></name></person-group>. <article-title>COVID-19 and Multiorgan Response.</article-title> <source>Curr Probl Cardiol</source>. <year>2020</year>;<volume>45</volume>(<issue>8</issue>):<elocation-id>100618</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.cpcardiol.2020.100618</pub-id><pub-id pub-id-type="pmid">32439197</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>BE</given-names></name><name><surname>Durstenfeld</surname><given-names>A</given-names></name><name><surname>Roehm</surname><given-names>PC</given-names></name></person-group>. <article-title>Viral Causes of Hearing Loss: A Review for Hearing Health Professionals.</article-title> <source>Trends Hear</source>. <year>2014</year>;<volume>18</volume>:<elocation-id>2331216514541361</elocation-id>. <pub-id pub-id-type="doi">10.1177/2331216514541361</pub-id><pub-id pub-id-type="pmid">25080364</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maharaj</surname><given-names>S</given-names></name><name><surname>Bello Alvarez</surname><given-names>M</given-names></name><name><surname>Mungul</surname><given-names>S</given-names></name><name><surname>Hari</surname><given-names>K</given-names></name></person-group>. <article-title>Otologic dysfunction in patients with COVID-19: A systematic review.</article-title> <source>Laryngoscope Investig Otolaryngol</source>. <year>2020</year>;<volume>5</volume>(<issue>6</issue>):<fpage>1192</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/lio2.498</pub-id><pub-id pub-id-type="pmid">33365394</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saniasiaya</surname><given-names>J</given-names></name></person-group>. <article-title>Hearing Loss in SARS-CoV-2: What Do We Know?</article-title> <source>Ear Nose Throat J</source>. <year>2021</year>;<volume>100</volume>:<fpage>152S</fpage>. <pub-id pub-id-type="doi">10.1177/0145561320946902</pub-id><pub-id pub-id-type="pmid">32755405</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cure</surname><given-names>E</given-names></name><name><surname>Cure</surname><given-names>MC</given-names></name></person-group>. <article-title>Comment on &#x201C;Hearing loss and COVID-19: A note&#x201D;.</article-title> <source>Am J Otolaryngol</source>. <year>2020</year>;<volume>41</volume>:<elocation-id>102513</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.amjoto.2020.102513</pub-id><pub-id pub-id-type="pmid">32386897</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sriwijitalai</surname><given-names>W</given-names></name><name><surname>Wiwanitkit</surname><given-names>V</given-names></name></person-group>. <article-title>Hearing loss and COVID-19: A note.</article-title> <source>Am J Otolaryngol</source>. <year>2020</year>;<volume>41</volume>:<elocation-id>102473</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.amjoto.2020.102473</pub-id><pub-id pub-id-type="pmid">32276732</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustafa</surname><given-names>MWM</given-names></name></person-group>. <article-title>Audiological profile of asymptomatic Covid-19 PCR-positive cases.</article-title> <source>Am J Otolaryngol</source>. <year>2020</year>;<volume>41</volume>:<elocation-id>102483</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.amjoto.2020.102483</pub-id><pub-id pub-id-type="pmid">32307189</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koumpa</surname><given-names>FS</given-names></name><name><surname>Forde</surname><given-names>CT</given-names></name><name><surname>Manjaly</surname><given-names>JG</given-names></name></person-group>. <article-title>Sudden irreversible hearing loss post COVID-19.</article-title> <source>BMJ Case Rep</source>. <year>2020</year>;<volume>13</volume>:<elocation-id>e238419</elocation-id>. <pub-id pub-id-type="doi">10.1136/bcr-2020-238419</pub-id><pub-id pub-id-type="pmid">33051251</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>B</given-names></name><name><surname>Hintze</surname><given-names>J</given-names></name><name><surname>Conlon</surname><given-names>B</given-names></name></person-group>. <article-title>Coronavirus disease 2019 and sudden sensorineural hearing loss.</article-title> <source>J Laryngol Otol</source>. <year>2020</year>;<volume>1&#x2013;3</volume>: <pub-id pub-id-type="doi">10.1017/S0022215120002145</pub-id><pub-id pub-id-type="pmid">33000716</pub-id></mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilic</surname><given-names>O</given-names></name><name><surname>Kalcioglu</surname><given-names>MT</given-names></name><name><surname>Cag</surname><given-names>Y</given-names></name><name><surname>Tuysuz</surname><given-names>O</given-names></name><name><surname>Pektas</surname><given-names>E</given-names></name><name><surname>Caskurlu</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.</article-title> <source>Int J Infect Dis</source>. <year>2020</year>;<volume>97</volume>:<fpage>208</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.06.023</pub-id><pub-id pub-id-type="pmid">32535294</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viola</surname><given-names>P</given-names></name><name><surname>Ralli</surname><given-names>M</given-names></name><name><surname>Pisani</surname><given-names>D</given-names></name><name><surname>Malanga</surname><given-names>D</given-names></name><name><surname>Sculco</surname><given-names>D</given-names></name><name><surname>Messina</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results.</article-title> <source>Eur Arch Otorhinolaryngol</source>. <year>2021</year>;<volume>278</volume>(<issue>10</issue>):<fpage>3725</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s00405-020-06440-7</pub-id><pub-id pub-id-type="pmid">33095432</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
